Clinical Trial Update: Dolutegravir Pediatric Liquid Formulation Study [Phase 1]

View source ↗

Summary

Phase 1 study update for dolutegravir pediatric liquid formulation; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Dolutegravir (dolutegravir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Phase 1 | Status: COMPLETED | Results posted: 2020-07-31